About Dr. Edward Gelber, M.D.
I am a psychiatrist with over 20 years of experience providing compassionate and effective mental health care. Based in North Bethesda, MD, I provide in-office treatment and telehealth care to patients across Maryland, and telehealth care throughout Virginia, New York State, and Massachusetts.
Education & Training
2002
Medical Degree (M.D.)
University of Pennsylvania School of Medicine
2006
Psychiatry Residency
University of Washington
Recognition & Achievements
Best Psychiatrist in North Bethesda
Business Rate · 2025–2026
Outstanding Resident Award
National Institute of Mental Health
View Publications
- Rioux L, Gelber EI, Parand L, Kazi HA, Yeh J, Wintering R, Bilker W, Arnold SE. Characterization of olfactory bulb glomeruli in schizophrenia. Schizophr Res. 2005 Sep 15;77(2-3):229-39.
- Gelber EI, Kohler CG, Bilker WB, Gur RC, Brensinger C, Siegel SJ, Gur RE. Symptom and demographic profiles in first-episode schizophrenia. Schizophr Res. 2004 Apr 1;67(2-3):185-94.
- Kristiansen K, Kroeze WK, Willins DL, Gelber EI, Savage JE, Glennon RA, Roth BL. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism. J Pharmacol Exp Ther. 2000 Jun;293(3):735-46.
- Gelber EI, Kroeze WK, Willins DL, Gray JA, Sinar CA, Hyde EG, Gurevich V, Benovic J, Roth BL. Structure and function of the third intracellular loop of the 5-hydroxytryptamine2A receptor: the third intracellular loop is alpha-helical and binds purified arrestins. J Neurochem. 1999 May;72(5):2206-14.
- Kroeze, WK, Gelber, EI, Kristiansen, K, Roth, BL. 1998. Identification of residues specifying 5-HT2A versus 5-HT2C receptor subtype specificity. Soc. for Neuroscience Abstracts 24 (308.9): 773.
- Hyde, EG, Gray, JA, Gelber, EI, Kroeze, WK, Roth, BL. 1997. Novel techniques for probing receptor-G-protein interactions: G-protein affinity chromatography and i3-ELISA. Soc. for Neuroscience Abstracts 23 (59.8): 128.
Areas of Interest & Expertise
Individualized Treatment Plans
Combining evidence-based interventions into a comprehensive approach.
Adolescents & Adults
Addressing evolving mental health needs in adolescents aged 11–17 years old and adults of all ages.
Therapeutic Innovation
Staying current with advancements in therapeutics and psychotropic medications.
Peer Collaboration
Engaging in ongoing peer review with psychiatric colleagues to ensure quality care.
Physician Health Consultant
Advisor to committees for physician health.